摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,2-二氢-2-氧代-3H-咪唑并[4,5-b]吡啶-3-羧酸,1,1-二甲基乙酯 | 1027159-01-8

中文名称
1,2-二氢-2-氧代-3H-咪唑并[4,5-b]吡啶-3-羧酸,1,1-二甲基乙酯
中文别名
3h咪唑并[4,5-b]吡啶-1-羧酸叔丁酯-2-酮
英文名称
1,2-Dihydro-2-oxo-3H-imidazo<4,5-b>pyridine-3-carboxylic acid 1,1-dimethylethyl ester
英文别名
tert-butyl 2-oxo-1,2-dihydro-3H-imidazo[4,5-b]pyridine-3-carboxylate;tert-Butyl 2-oxo-1H-imidazo[4,5-b]pyridine-3(2H)-carboxylate;tert-butyl 2-oxo-1H-imidazo[4,5-b]pyridine-3-carboxylate
1,2-二氢-2-氧代-3H-咪唑并[4,5-b]吡啶-3-羧酸,1,1-二甲基乙酯化学式
CAS
1027159-01-8
化学式
C11H13N3O3
mdl
——
分子量
235.243
InChiKey
OYIYQMHHTPPHAT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.288±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    71.5
  • 氢给体数:
    1
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2933990090

SDS

SDS:f354d1a179688d3cb265c5196833b9af
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1,2-二氢-2-氧代-3H-咪唑并[4,5-b]吡啶-3-羧酸,1,1-二甲基乙酯potassium carbonateN,N-二异丙基乙胺 作用下, 以 N,N-二甲基甲酰胺乙腈 为溶剂, 反应 15.0h, 生成 1-(4-(4-(4-fluorobenzoyl)piperidin-1-yl)butyl)-1H-imidazo[4,5-b]pyridin-2(3H)-one
    参考文献:
    名称:
    灵长类动物大脑中双5-羟色胺7(5-HT 7)/ 5-羟色胺2A(5-HT 2A)受体拮抗剂的合理设计,药物调节和合成,并通过[ 18 F] -PET成像进行评估
    摘要:
    我们报告了46个含叔胺的N-烷基化苯并[ d ]咪唑-2(3 H)-ones,咪唑并[4,5 - b ]吡啶-2(3 H)-ones,咪唑并[4,5 ]的合成- ç ]吡啶-2(3 H ^) -酮,苯并[ d ]唑-2(3 H ^) -酮,恶唑并[4,5- b ]吡啶-2(3 H ^) -酮和ñ,ñ ' -二烷基化的苯并[ d ]咪唑-2(3 H)-ones。针对5-HT 7 R,5-HT 2A R,5-HT 1A R和5-HT 6评估了这些化合物R为有效的双重5-HT 7 / 5-HT 2A血清素受体配体。对芳香环及其取代基,烷基链长和叔胺的结构-活性关系进行了彻底的研究。1-(4-(4-(4-氟苯甲酰基)哌啶-1-基)丁基)-1 H-苯并[ d ]咪唑-2(3 H)-一(79)和1-(6-(4- (4-氟苯甲酰基)哌啶-1-基己基)-1 H-苯并[ d ]咪唑-2(3 H)-一(81)
    DOI:
    10.1021/acs.jmedchem.5b00874
  • 作为产物:
    参考文献:
    名称:
    灵长类动物大脑中双5-羟色胺7(5-HT 7)/ 5-羟色胺2A(5-HT 2A)受体拮抗剂的合理设计,药物调节和合成,并通过[ 18 F] -PET成像进行评估
    摘要:
    我们报告了46个含叔胺的N-烷基化苯并[ d ]咪唑-2(3 H)-ones,咪唑并[4,5 - b ]吡啶-2(3 H)-ones,咪唑并[4,5 ]的合成- ç ]吡啶-2(3 H ^) -酮,苯并[ d ]唑-2(3 H ^) -酮,恶唑并[4,5- b ]吡啶-2(3 H ^) -酮和ñ,ñ ' -二烷基化的苯并[ d ]咪唑-2(3 H)-ones。针对5-HT 7 R,5-HT 2A R,5-HT 1A R和5-HT 6评估了这些化合物R为有效的双重5-HT 7 / 5-HT 2A血清素受体配体。对芳香环及其取代基,烷基链长和叔胺的结构-活性关系进行了彻底的研究。1-(4-(4-(4-氟苯甲酰基)哌啶-1-基)丁基)-1 H-苯并[ d ]咪唑-2(3 H)-一(79)和1-(6-(4- (4-氟苯甲酰基)哌啶-1-基己基)-1 H-苯并[ d ]咪唑-2(3 H)-一(81)
    DOI:
    10.1021/acs.jmedchem.5b00874
点击查看最新优质反应信息

文献信息

  • Regiospecific Functionalization of 1,3-Dihydro-2H-benzimidazol-2-one and Structurally Related Cyclic Urea Derivatives
    作者:Nicholas A. Meanwell、Sing Yuen Sit、Jinnian Gao、Henry S. Wong、Qi Gao、Denis R. St. Laurent、Neelakantan Balasubramanian
    DOI:10.1021/jo00111a014
    日期:1995.3
    Methods for selectively protecting one of the degenerate nitrogen atoms of the cyclic urea derivatives 1,3-dihydro-2H-benzimidazol-2-one (6a), 1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-one (11), 1,3-dihydro-2H-imidazo[4,5-b]quinolin-2-ones (20), 1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one (22), and 1,3-dihydro-4-phenyl-2H-imidazol-2-one (27) were developed. Heating these cyclic ureas with ethyl 2-pyridyl carbonate in the presence of a base in CH3CN at reflux or DMF at 100 degrees C cleanly provided the monoethoxycarbonyl derivatives 7a, 12, 21, 23, and 28, respectively. Alternatively, treatment of 6a with an excess of diethyl pyrocarbonate or di-tert-butyl dicarbonate afforded the bis-alkoxycarbonyl derivatives 8a and 8b, respectively, which underwent disproportionation to 7a and 7b upon heating with 1 mol equiv of 6a and K2CO3 in CH3CN at reflux. The regiochemistry of the introduction of alkoxycarbonyl groups to benzimidazol-2-one derivatives was not significantly influenced by an electron-withdrawing (CF3, 6b) or an electron-donating (OCH3, 6c) substituent at C-5 of the heterocyclic ring. However, the reaction was found to be sensitive to steric factors since a chlorine substituent ortho to one of the urea N atoms (6e) completely directed the alkoxycarbonyl moiety to the less sterically encumbered N atom, affording a single product (7f, 7g). Alkylation of 7a-g proceeded efficiently to provide products 10a-10ag after removal of the protecting group. Halogenation of monoprotected benzimidazol-2-one 7a occurred regiospecifically to give the monohalo derivatives 7h, 7i, and 7k, the identity of which were readily established from the characteristic chemical shift and spin coupling pattern in their 1H NMR spectra. A protecting group interchange strategy that took advantage of the distinctive chemical reactivities of the EtO(2)C and t-BuO(2)C protecting groups toward isopropylamine was developed that provided access to the isomerically substituted series of monohalo, mono-N-alkylated benzimidazol-2-ones 71 and 7m. The efficient derivatization of the unprotected N atom of these monoprotected cyclic urea derivatives was accomplished by treating with activated and unactivated halides in the. presence of K2CO3 or exposure to alcohols under Mitsunobu conditions. In several cases, mixtures of O- and N-alkylated products were produced which were readily separated by chromatography. Alkylation of 7h with activated halides, using K2CO3 in CH3CN at reflux, occurred without protecting group equilibration; however, a mixture of isomeric alkylated products was obtained when 7h was heated at 110 degrees C in DMF with cyclohexylmethyl bromide in the presence of K2CO3 as the base. Derivatization of 7h under Mitsunobu reaction conditions proceeded with retention of the topological substituent relationships. Subsequent removal of the alkoxycarbonyl moiety afforded monoalkylated cyclic urea derivatives.
  • CN116478211
    申请人:——
    公开号:——
    公开(公告)日:——
查看更多

同类化合物

阿法拉定A,TFA 钠咪唑并[1,2-a]吡啶-2-羧酸酯水合物(1:1:1) 钠(E)-2-氰基-3-[2,8-二(丙-2-基氧基)咪唑并[3,2-a]吡啶-3-基]丙-2-烯酸酯 诺白拉斯啶 苯酚,4-(5,6,7,8-四氢咪唑并[1,2-a]吡啶-8-基)- 米诺膦酸 米诺磷酸一水合物 硫酸利美戈潘 盐酸法屈唑半水合物 盐酸依格列汀 甲基咪唑并[1,5-A]吡啶-1-甲酸叔丁酯 甲基3-氨基咪唑并[1,2-a]吡啶-5-羧酸酯 甲基-(7-甲基咪唑并[1,2-A〕吡啶-2-基甲基)-胺 甲基-(5-甲基-咪唑并[1,2-A]吡啶-2-甲基)-胺 甲基 2-甲基咪唑并[1,2-a]吡啶-3-羧酸 环戊烷羧酸2-氨基-4-亚甲基-,(1R,2S)-(9CI) 环巴胺抑制剂1 泰妥拉唑 法倔唑盐酸盐 法倔唑 沃利替尼(对映异构体) 沃利替尼 氨基膦酸杂质14 戊酰胺,N-(2-丁基-1H-咪唑并[4,5-b]吡啶-6-基)- 巴马鲁唑 奥克塞米索 地扎胍宁甲磺酸盐 地扎胍宁 土大黄甙 咪唑磺隆 咪唑并吡啶-6-甲胺盐酸盐 咪唑并吡啶-2-酮盐酸盐 咪唑并吡啶-2-酮 咪唑并二甲基吡啶 咪唑并[2,1-a]异喹啉-2(3H)-酮 咪唑并[1,5-a]喹唑啉,6-氯-3-(3-环丙基-1,2,4-噁二唑-5-基)-5-(4-吗啉基)- 咪唑并[1,5-a]吡啶-8-胺 咪唑并[1,5-a]吡啶-8-羧酸乙酯 咪唑并[1,5-a]吡啶-8-甲醛 咪唑并[1,5-a]吡啶-7-羧酸甲酯 咪唑并[1,5-a]吡啶-7-羧酸乙酯 咪唑并[1,5-a]吡啶-6-羧酸甲酯 咪唑并[1,5-a]吡啶-6-羧酸乙酯 咪唑并[1,5-a]吡啶-5-胺 咪唑并[1,5-a]吡啶-5-羧酸甲酯 咪唑并[1,5-a]吡啶-5-羧酸乙酯 咪唑并[1,5-a]吡啶-5-甲醛 咪唑并[1,5-a]吡啶-3-羧酸乙酯 咪唑并[1,5-a]吡啶-3-磺酰胺 咪唑并[1,5-a]吡啶-3-甲醛